Product image of Memantina Aristo (Memantine Hydrochloride) supplied by GNH India

Memantina Aristo

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantina Aristo (Memantine Hydrochloride)

Memantine, the active ingredient in Memantina Aristo, is a NMDA receptor antagonist presented as an oral tablet for oral use. It treats Alzheimer’s disease in adults by helping to preserve cognition and daily functioning.

GNH India supplies Memantina Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aristo Pharma Iberia, S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Memantina Aristo is an NMDA receptor antagonist indicated for the treatment of Alzheimer’s disease, a neurodegenerative disorder affecting memory and cognition.
  • Alzheimer’s disease (moderate to severe): helps maintain cognition and daily functioning in patients with moderate to severe disease.
  • Mild‑to‑moderate Alzheimer’s disease: may provide modest cognitive benefit in earlier stages.
  • Behavioral symptoms of dementia: may reduce agitation and improve overall patient behavior.

How It Works

  • Memantine acts as a non‑competitive antagonist at the NMDA (N‑methyl‑D‑aspartate) receptor. By binding to the receptor-associated ion channel, it blocks excessive calcium influx caused by overstimulation, thereby reducing excitotoxic neuronal injury and supporting neuronal survival in Alzheimer’s disease.

Side Effects

Memantina Aristo may cause a range of adverse reactions. Most are mild and reversible.

Common Side Effects

  • Dizziness
  • Headache
  • Constipation
  • Confusion
  • Hypertension
  • Fatigue

Serious or Rare Side Effects

  • Seizures
  • Severe allergic reactions (rash, angioedema)
  • Hepatic dysfunction
  • Stevens‑Johnson syndrome
  • Suicidal thoughts or behavior

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety factors.

  • Renal impairment: assess renal function and adjust dose if needed.
  • History of seizures: monitor closely for seizure activity.
  • Cardiovascular disease: monitor blood pressure regularly.
  • Concurrent use with other NMDA antagonists: avoid combined therapy.
  • Pregnancy: use only if potential benefit outweighs risk.
  • Store at ambient temperature: keep in the original container, protect from moisture.

Avoid Interactions

Memantina Aristo can interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Amantadine: additive NMDA antagonism may increase neurotoxicity.
  • Ketamine: combined NMDA blockade can exacerbate CNS effects.
  • Strong renal toxicants (e.g., high‑dose NSAIDs): may worsen renal clearance.

Moderate Interactions (Monitor Closely)

  • Anticholinesterase inhibitors: monitor for additive cognitive effects.
  • Diuretics: watch renal function and electrolytes.
  • Antihypertensives: observe for blood‑pressure changes.

Frequently Asked Questions

Memantina Aristo contains memantine hydrochloride and is prescribed for the treatment of Alzheimer’s disease, particularly in patients with moderate to severe cognitive impairment.

Memantine blocks the NMDA receptor’s ion channel in a non‑competitive manner, reducing excessive calcium influx and preventing excitotoxic neuronal damage that contributes to cognitive decline.

The specific dose and titration schedule are determined by the prescribing clinician based on the patient’s condition, renal function, and response to therapy.

Safety data are limited; the product should be used during pregnancy or lactation only if the potential benefit justifies the possible risk to the fetus or infant.

Submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors. It is typically used in moderate to severe disease and may be combined with an inhibitor for complementary mechanisms.

Store the tablets at ambient temperature, below 25 °C, in the original packaging and protect them from moisture and direct sunlight.

The medication is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional.

Serious adverse events can include seizures, severe allergic reactions such as rash or angioedema, hepatic dysfunction, and rare psychiatric effects like suicidal thoughts.

Patients with known hypersensitivity to memantine or any component of the formulation, and those with severe renal impairment without appropriate dose adjustment, should avoid using this product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT